• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Stemline Therapeutics, Inc. (STML)

    -NasdaqCM
    16.02 0.74(4.84%) Dec 17, 4:00PM EST
    Add to Portfolio
    Prev Close:15.28
    Open:15.47
    Bid:13.50 x 100
    Ask:N/A
    1y Target Est:56.00
    Beta:-4.709
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:15.22 - 16.27
    52wk Range:10.50 - 31.48
    Volume:111,590
    Avg Vol (3m):132,305
    Market Cap:207.60M
    P/E (ttm):N/A
    EPS (ttm):-2.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for STML

    Comparison

    Symbol% ChgMkt Cap
    STMLUp 4.84%207.60M
    OMED603.80M
    VSTM215.96M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):695.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.31
    Quarterly EPS Est (Dec-14) :-0.62
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback